A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1997
12/04/1997	CA2256372A1 Apoptosis associated protein bbk
12/04/1997	CA2256358A1 Compositions and methods for antisense inhibition of protein translation
12/04/1997	CA2256344A1 7.alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7.alpha.-(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents
12/04/1997	CA2256312A1 Prion protein binding proteins and uses thereof
12/04/1997	CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997	CA2255927A1 Ebv ctl epitopes
12/04/1997	CA2255755A1 Absolute molecular weight polymers and methods for their use
12/04/1997	CA2255727A1 Pharmaceutical for treating of neurological and neuropsychiatric disorders
12/04/1997	CA2255677A1 Cytostatic sterols
12/04/1997	CA2255612A1 Aryl substituted cyclic amines as selective dopamine d3 ligands
12/04/1997	CA2255559A1 Carbohydrate derivatives and their solid-phase synthesis
12/04/1997	CA2254983A1 Concentrated antibody preparation
12/04/1997	CA2254943A1 Beta-lactams
12/04/1997	CA2254744A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
12/04/1997	CA2254339A1 Use of estrogen to modify the amount of serotonin transporter or its mrna
12/04/1997	CA2253818A1 Mammalian tolloid-like gene and protein
12/04/1997	CA2253410A1 New improved formulation for treatment of thromboembolism
12/04/1997	CA2253406A1 Benzoxazinone dopamine d4 receptor antagonists
12/04/1997	CA2252747A1 Novel pyridazine compounds
12/04/1997	CA2252718A1 Compositions for use in embolizing blood vessels
12/04/1997	CA2252606A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis[hydrazine carboximidamide]
12/04/1997	CA2252601A1 Process of preparing 2,2'-(1-methyl-1,2-ethanediylidene)bis¬hydrazine carboximidamide\|
12/04/1997	CA2250038A1 Substituted amidinobenzene derivatives and medicinal compositions thereof
12/04/1997	CA2227811A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/04/1997	CA2206975A1 Therapeutic agent for dermatosis
12/03/1997	EP0810225A1 Process for producing paroxetine
12/03/1997	EP0810223A1 Adamantyl substituted oxindoles as pharmaceutical agents
12/03/1997	EP0810220A1 Arylacrylamide derivatives as 5HT1 agonists or antagonists
12/03/1997	EP0810218A1 6-Benzyl-2H-pyridazin-3-one derivatives,their preparation and their use as inhibitors of prostaglandin G/H synthase I and II (COX I and COX II)
12/03/1997	EP0810217A1 Pyrazole derivatives and their pharmaceutical use as smooth muscle cell growth inhibitors
12/03/1997	EP0810216A1 Derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
12/03/1997	EP0810209A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/03/1997	EP0810208A2 N-substituted Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/03/1997	EP0810207A1 Bis-ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/03/1997	EP0810206A1 Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
12/03/1997	EP0810205A1 Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/03/1997	EP0809996A2 Interferon conjugates
12/03/1997	EP0809995A1 New diacerhein formulations obtained by active principle inclusion in polysaccharide hydrogels
12/03/1997	EP0809708A1 Potentiators of antibacterial agents
12/03/1997	EP0809705A1 Nucleic acid-containing composition, preparation and use thereof
12/03/1997	EP0809698A1 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE Int6
12/03/1997	EP0809660A1 Polymeric compounds
12/03/1997	EP0809657A1 Process for producing chitosan-glucan complexes, compounds producible therefrom and their use
12/03/1997	EP0809644A1 4-substituted cephem derivatives as elastase inhibitors
12/03/1997	EP0809642A1 Imidazo 1,2-a]pyridines for the treatment of cns and cardiac diseases
12/03/1997	EP0809641A1 Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity
12/03/1997	EP0809634A1 Novel uses for barbituric acid analogs
12/03/1997	EP0809630A1 Indole derivatives with affinity for the cannabinoid receptor
12/03/1997	EP0809627A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
12/03/1997	EP0809624A1 Alkylcarboxy amino acids-modulators of the kainate receptor
12/03/1997	EP0809623A1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them
12/03/1997	EP0809622A1 Anti-inflammatory benzoic acid derivatives
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809516A1 Medicinal combination useful for in vivo exogenic transfection and expression
12/03/1997	EP0809515A1 Therapeutic inhibitor of vascular smooth muscle cells
12/03/1997	EP0809514A1 Pharmaceutical composition for parenteral application containing an indole-carboxylic acid
12/03/1997	EP0809505A1 Method of treating chronic progressive vascular diseases
12/03/1997	EP0809504A1 Anti-viral triaza compounds
12/03/1997	EP0809503A1 Method of lessening the risk of vertebral fractures
12/03/1997	EP0809502A1 Method of lessening the risk of non-vertebral bone fractures
12/03/1997	EP0809501A1 Novel pharmaceutical formulation
12/03/1997	EP0809500A1 Novel glucocorticoid response elements
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0809498A1 Novel pharmaceutical combination
12/03/1997	EP0809497A1 Extended-release solid oral dosage forms of drugs having low solubility in water
12/03/1997	EP0809496A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of idiopathic or physiologic gynaecomastia
12/03/1997	EP0809495A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
12/03/1997	EP0809494A1 The use of heterocyclic compounds
12/03/1997	EP0809493A1 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
12/03/1997	EP0809492A1 Il-8 receptor antagonists
12/03/1997	EP0809491A1 Use of matrix metalloproteinase inhibitors for the treatment of diseases mediated by tnf-alpha
12/03/1997	EP0809490A1 Use of lck sh2 specific compounds to treat autoimmune diseases and allograft rejection
12/03/1997	EP0809437A1 Thiols to promote hematopoietic progenitor cell growth
12/03/1997	EP0746343A4 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE -i(IN VIVO) OR -i(EX VIVO)
12/03/1997	EP0717733B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
12/03/1997	EP0691960B1 Antipsychotic benzimidazole derivatives
12/03/1997	EP0689539B1 Antipsychotic indazole derivatives
12/03/1997	EP0689537B1 Method and apparatus for extracting taxol from source materials
12/03/1997	EP0660825B1 Anti-inflammatory macrolactam (cyclamenol)
12/03/1997	EP0533838B1 Nucleic acid ligands
12/03/1997	CN1166836A Novel androstanes with inducing hypothalamic effects
12/03/1997	CN1166834A Benzopyram and benzo-fused compounds, their preparation and their use as leukotriene B4'(LTB4) antagonists
12/03/1997	CN1166831A Novel benzyl pyrimidines
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166787A Lubeluzole intravenous solutions
12/03/1997	CN1166786A Retroviral protease inhibitor combinations
12/03/1997	CN1166785A Pharmaceutical control of inflammation
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1166320A Composite of zinc containing compound and glutamines
12/03/1997	CN1166319A Compound hypoglycemic agent
12/03/1997	CN1166318A Vanalover hydrochloride and its medicine composite for curing hepatitis B
12/03/1997	CN1166317A Compound women's moistening cleaner
12/03/1997	CN1166316A Combination therapy to treat osteoporosis
12/03/1997	CN1036592C Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/03/1997	CN1036591C Carbamates of repamycin
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/03/1997	CN1036589C New thiazolylbenzofuran derivatives, process for preparation thereof and pharmaceutical composition comprising the same
12/03/1997	CN1036588C Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses

1 ... 6717 6718 6719 6720 6721 6722 6723 6724 6725 6726 6727 6728 6729 6730 6731 6732 6733 6734 6735 6736 6737 ... 7860